Combining bioinformatics and biological detection to identify novel biomarkers for diagnosis and prognosis of pulmonary tuberculosis

References

1. ↵
   1. Schluger NW

   (2017) AJRCCM:100-Year Anniversary. Focus on Tuberculosis. Am J Respir Crit Care Med 195:1112–1114.

   OpenUrl
2. ↵
   1. Furin J,
   2. Cox H,
   3. Pai M

   (2019) Tuberculosis. Lancet 393:1642–1656.

   OpenUrlCrossRef
3. ↵
   1. Bloom CI,
   2. Graham CM,
   3. Berry MP,
   4. Rozakeas F,
   5. Redford PS,
   6. Wang Y,
   7. et al.

   (2017) The circular RNA of peripheral blood mononuclear cells:Hsa_circ_0005836 as a new diagnostic biomarker and therapeutic target of active pulmonary tuberculosis. Mol Immunol 90:264–272.

   OpenUrl
4. ↵
   1. Walzl G,
   2. McNerney R,
   3. du Plessis N,
   4. Bates M,
   5. McHugh TD,
   6. Chegou NN,
   7. et al.

   (2018) Tuberculosis:advances and challenges in development of new diagnostics and biomarkers. Lancet Infect Dis 18:e199–e210.

   OpenUrlCrossRefPubMed
5. ↵
   1. Sampath P,
   2. Moideen K,
   3. Ranganathan UD,
   4. Bethunaickan R

   (2018) Monocyte subsets:phenotypes and function in tuberculosis infection. Front Immunol 9:1726.

   OpenUrlCrossRef
6. ↵
   1. Kim MJ,
   2. Wainwright HC,
   3. Locketz M,
   4. Bekker LG,
   5. Walther GB,
   6. Dittrich C,
   7. et al.

   (2010) Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol Med 2:258–274.

   OpenUrlAbstract/FREE Full Text
7. ↵
   1. Singhal A,
   2. Jie L,
   3. Kumar P,
   4. Hong GS,
   5. Leow MK,
   6. Paleja B,
   7. et al.

   (2014) Metformin as adjunct antituberculosis therapy. Sci Transl Med 6:263ra159.

   OpenUrlAbstract/FREE Full Text
8. ↵
   1. Verway M,
   2. Bouttier M,
   3. Wang TT,
   4. Carrier M,
   5. Calderon M,
   6. An BS,
   7. et al.

   (2013) Vitamin D induces interleukin-1? Expression:paracrine macrophage epithelial signaling controls M. tuberculosis Infection. PLoS Pathog 9:e1003407.

   OpenUrlCrossRefPubMed
9. ↵
   1. Preez ID,
   2. Luies L,
   3. Loots DT

   (2017) Metabolomics biomarkers for tuberculosis diagnostics:current status and future objectives. Biomark Med 11:179–194.

   OpenUrlCrossRef
10. ↵
    1. Singhania A,
    2. Wilkinson RJ,
    3. Rodrigue M,
    4. Haldar P,
    5. O'Garra A

    (2018) The value of transcriptomics in advancing knowledge of the immune response and diagnosis in tuberculosis. Nat Immunol 19:1159–1168.

    OpenUrlPubMed
11. ↵
    1. Nguyen DT,
    2. Graviss EA

    (2018) Development and validation of a prognostic score to predict tuberculosis mortality. J Infect 77:283–290.

    OpenUrlPubMed
12. ↵
    1. Pefura-Yone EW,
    2. Balkissou AD,
    3. Poka-Mayap V,
    4. Fatime-Abaicho HK,
    5. Enono-Edende PT,
    6. Kengne AP

    (2017) Development and validation of a prognostic score during tuberculosis treatment. BMC Infect Dis 17:251.

    OpenUrl
13. ↵
    1. Wang M,
    2. Kong W,
    3. He B,
    4. Li Z,
    5. Song H,
    6. Shi P,
    7. et al.

    (2018) Vitamin D and the promoter methylation of its metabolic pathway genes in association with the risk and prognosis of tuberculosis. Clin Epigenetics 10:118.

    OpenUrl
14. ↵
    1. Zheng X,
    2. Li T,
    3. Chen Y,
    4. Pan H,
    5. Zhang Z,
    6. Dai Y,
    7. et al.

    (2017) Genetic polymorphisms of the P2X7 gene associated with susceptibility to and prognosis of pulmonary tuberculosis. Infect Genet Evol 53:24–29.

    OpenUrlCrossRef
15. ↵
    1. Weiner J,
    2. Kaufmann SH

    (2017) High-throughput and computational approaches for diagnostic and prognostic host tuberculosis biomarkers. Int J Infect Dis 56:258–262.

    OpenUrlCrossRef
16. ↵
    1. Luies L,
    2. Reenen MV,
    3. Ronacher K,
    4. Walzl G,
    5. Loots DT

    (2017) Predicting tuberculosis treatment outcome using metabolomics. Biomark Med 11:1057–1067.

    OpenUrlCrossRef
17. ↵
    1. Wang G,
    2. van Driel BJ,
    3. Liao G,
    4. O'Keeffe MS,
    5. Halibozek PJ,
    6. Flipse J,
    7. et al.

    (2015) Migration of myeloid cells during inflammation is differentially regulated by the cell surface receptors SLAMF1 and SLAMF8. PLoS One 10:e0121968.

    OpenUrlCrossRef
18. ↵
    1. Deng M,
    2. Gui X,
    3. Kim J,
    4. Xie L,
    5. Chen W,
    6. Li Z,
    7. et al.

    (2018) LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature 562:605–609.

    OpenUrlPubMed
19. ↵
    1. Peng L,
    2. Zhang H,
    3. Hao Y,
    4. Xu F,
    5. Yang J,
    6. Zhang R,
    7. et al.

    (2016) Reprogramming macrophage orientation by microRNA 146b targeting transcription factor IRF5. EBio Medicine 14:83–96.

    OpenUrl
20. ↵
    1. Zhai W,
    2. Wu F,
    3. Zhang Y,
    4. Fu Y,
    5. Liu Z

    (2019) The Immune Escape Mechanisms of Mycobacterium Tuberculosis. Int J Mol Sci 20:pii:E340.

    OpenUrl
21. ↵
    1. Lorenzetti R,
    2. Zullo A,
    3. Ridola L,
    4. Diamanti AP,
    5. Laganà B,
    6. Gatta L,
    7. et al.

    (2014) Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents:a systematic review of randomized controlled trials. Ann Med 46:547–554.

    OpenUrlCrossRefPubMed
22. ↵
    1. Chen Z,
    2. Wang T,
    3. Liu Z,
    4. et al.

    (2015) Inhibition of Autophagy by MiR-30A Induced by Mycobacteria tuberculosis as a Possible Mechanism of Immune Escape in Human Macrophages. Jpn J Infect Dis 68:420–424.

    OpenUrl